Article Text

PDF
Using NSAIDs in cardiovascular disease

Abstract

The risk of unwanted cardiovascular effects associated with NSAIDs has been publicised in the UK in recent years by the Medicines and Healthcare products Regulatory Agency (MHRA)1,2 and the National Prescribing Centre (NPC).3 Here we consider the evidence on cardiovascular risk in the context of other unwanted effects of NSAIDs (particularly those relating to the gastrointestinal tract and the kidneys), and offer practical advice on the use of NSAIDs in patients with cardiovascular disease.

Statistics from Altmetric.com

  • Relevant BNF section: BNF 10.1.1

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.